Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...
Over the recent years, a positive impact has been seen on the growth of the market. Since biopharmaceutical innovators are at ...
Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader with a question about using ivermectin to treat scabies.
LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant strains of SARS-CoV-2.
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...
The blood-borne virus - dubbed a 'silent killer' - often progresses so slowly it can largely go unnoticed for decades ...
Island Pharmaceuticals CEO Dr David Foster has described Q1 FY25 as a “breakthrough” for the clinical stage biotech, which is ...
Doctors will usually prescribe oseltamivir (Tamiflu) or baloxavir (Xofluza) to treat the flu, although zanamivir (Relenza Diskhaler) is also an option. OTC fever-reducing medication like acetaminophen ...
Pfizer, which is under pressure from activist investor Starboard, on Tuesday (Oct 29) topped third-quarter estimates as sales of its Covid-19 treatment Paxlovid blew past Wall Street expectations.